<li>alvimopan<p>sirolimus will increase the level or effect of alvimopan by  P-glycoprotein (MDR1) efflux transporter. Minor/Significance Unknown.</p></li><li>armodafinil<p>sirolimus will increase the level or effect of armodafinil by  P-glycoprotein (MDR1) efflux transporter. Minor/Significance Unknown.</p></li><li>fexofenadine<p>sirolimus will increase the level or effect of fexofenadine by  P-glycoprotein (MDR1) efflux transporter. Minor/Significance Unknown.</p></li><li>fluvoxamine<p>fluvoxamine will increase the level or effect of sirolimus by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>loratadine<p>sirolimus will increase the level or effect of loratadine by  P-glycoprotein (MDR1) efflux transporter. Minor/Significance Unknown.</p></li><li>ruxolitinib<p>sirolimus will increase the level or effect of ruxolitinib by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li>